About Nervigesic
Nervigesic 300 mg is a pregabalin formulation manufactured by Signature Pharmaceuticals Ltd for laboratory research applications. Pregabalin is a gamma-aminobutyric acid (GABA) analogue that modulates voltage-gated calcium channels in neural tissue models. Research scientists examine pregabalin’s mechanism of action through its binding to the α2δ subunit of voltage-dependent calcium channels, which reduces calcium influx and subsequent neurotransmitter release in experimental systems.
Laboratory investigations demonstrate pregabalin’s unique pharmacological profile compared to traditional GABA compounds. Unlike direct GABA receptor agonists, pregabalin functions through calcium channel modulation, making it valuable for neuropharmacology research. Scientists at Stroid UK Shop utilise this compound alongside other pregabalin research materials to study gabapentinoid mechanisms and calcium channel physiology.
Laboratory Research Applications
Research teams investigate pregabalin’s effects on calcium channel subtypes and neurotransmitter modulation in controlled laboratory environments. Studies examine the compound’s binding affinity to α2δ-1 and α2δ-2 subunits of voltage-gated calcium channels, providing insights into calcium-dependent cellular processes. Neuroscience researchers analyse pregabalin’s impact on glutamate, noradrenaline, and substance P release in tissue culture models.
Comparative studies evaluate pregabalin against other research compounds available in our SARMs collection and peptide research materials to understand diverse molecular targets. Laboratory protocols investigate dose-response relationships, binding kinetics, and cellular pathway modulation using standardised analytical techniques. Research applications include calcium channel pharmacology, neurotransmitter regulation studies, and gabapentinoid mechanism investigations.
Product Specifications
| Parameter | Value |
|---|---|
| Active Ingredient | Pregabalin 300mg |
| Manufacturer | Signature Pharmaceuticals Ltd |
| Formulation | Tablet |
| CAS Number | 148553-50-8 |
| Molecular Formula | C₈H₁₇NO₂ |
| Molecular Weight | 159.23 g/mol |
| Storage Conditions | Room temperature, dry environment |
| Research Purity | Pharmaceutical grade |
Research Compliance Statement
Nervigesic 300 mg tablets are intended exclusively for in-vitro laboratory research and analytical testing purposes. This pregabalin formulation is not approved for human consumption, therapeutic use, or any clinical applications. Research institutions must ensure proper laboratory safety protocols and regulatory compliance when handling this compound. Scientists should consult relevant safety data sheets and institutional guidelines before conducting research studies with pregabalin materials.
